Industry Focus
Healthcare: What's The Most Important Number In Gilead Sciences Earnings Report?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:15:25
- Mais informações
Informações:
Sinopse
Motley Fool analysts dig into Teva Pharmaceuticals recent M&A and debate the single most important number reported in Gilead Sciences second quarter earnings results.
